Keyphrases
HeartMate II
100%
Transplantation Therapy
100%
Left Ventricular Assist Device
100%
Bridge to Transplantation
100%
Adverse Events
100%
Improved Survival
100%
Right Ventricular Function
28%
Patient Survival
28%
Gastrointestinal Bleeding
28%
Device Infection
28%
Anticoagulant Therapy
28%
Transplant Patients
14%
Bleeding
14%
Destination Therapy
14%
Pump Thrombosis
14%
Mortality Rate
14%
Congenital Heart Disease
14%
Critically Ill Patients
14%
Neurologic
14%
Device Failure
14%
Low Mortality
14%
Underlying Disease
14%
Patient Death
14%
Mediastinal Bleeding
14%
Right Ventricular Assist Device
14%
Single-center Experience
14%
Major Adverse Events
14%
Pulsatile
14%
Continuous Flow System
14%
Peripartum Cardiomyopathy
14%
HeartMate XVE
14%
Re-exploration
14%
Myocarditis
14%
Kaplan-Meier Analysis
14%
Survival Events
14%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Anticoagulation Therapy
66%
Thromboembolism
66%
Gastrointestinal Hemorrhage
66%
Device Infection
66%
Heart Right Ventricle Failure
66%
Congenital Heart Disease
33%
Bleeding
33%
Mortality Rate
33%
Thrombosis
33%
Peripartum Cardiomyopathy
33%
Myocarditis
33%
Diseases
33%
Medicine and Dentistry
Left Ventricular Assist Device
100%
Adverse Event
100%
Thromboembolism
33%
Gastrointestinal Bleeding
33%
Anticoagulant Therapy
33%
Heart Right Ventricle Failure
33%
Device Infection
33%
Persistent Truncus Arteriosus
16%
Thrombosis
16%
Bleeding
16%
Mortality Rate
16%
Kaplan Meier Method
16%
Myocarditis
16%
Peripartum Cardiomyopathy
16%
Ventricular Assist Device
16%
Diseases
16%
Nursing and Health Professions
Left Ventricular Assist Device
100%
Adverse Event
100%
Gastrointestinal Hemorrhage
15%
Thromboembolism
15%
Device Infection
15%
Anticoagulant Therapy
15%
Heart Right Ventricle Failure
15%
Congenital Heart Disease
7%
Right Ventricular Assist Device
7%
Mortality Rate
7%
Bleeding
7%
Kaplan Meier Method
7%
Thrombosis
7%
Myocarditis
7%
Peripartum Cardiomyopathy
7%
Diseases
7%